United States was Rapid Micro Biosystems’s largest region in fiscal 2025, bringing in $13.43M of $33.59M (40%).
| Geography | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| United States | $8.77M | $9.88M | $10.64M | $13.43M | ||
| All Other Countries | $2.96M | $3.97M | $6.64M | $5.77M | ||
| Switzerland | $2.76M | $4.00M | $5.67M | $6.02M | ||
| Germany | $2.65M | $2.12M | $3.05M | $5.77M | ||
| Japan | — | $2.56M | $2.05M | $2.60M | ||
| Total | $17.13M | $22.52M | $28.05M | $33.59M |
Rapid Micro Biosystems brought in $33.59M from its five regions in fiscal 2025, the year ended December 31, 2025. That was up 19.7% from $28.05M in fiscal 2024. United States was the largest at $13.43M (40.0%), ahead of Switzerland at $6.02M (17.9%) and All Other Countries at $5.77M (17.2%). The other two regions brought in $8.36M combined.
Compared with fiscal 2024, Germany grew fastest, up 89.2% to $5.77M, while All Other Countries fell the most, down 13.1% to $5.77M.
Rapid Micro Biosystems began breaking out Japan in fiscal 2023, when it brought in $2.56M.
Product was Rapid Micro Biosystems’s largest product and service line in fiscal 2025, bringing in $23.43M of $33.59M (70%).
| Product and Service | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Product | $11.06M | $14.81M | $18.73M | $23.43M | ||
| Product Revenue | — | — | — | — | ||
| Service | $6.08M | $7.71M | $9.32M | $10.16M | ||
| Service Revenue | — | — | — | — | ||
| Non-Commercial Revenue - Non-Recurring | — | — | — | — | ||
| Non-Commercial Revenue | — | — | — | — | ||
| Total | $17.13M | $22.52M | $28.05M | $33.59M |
Rapid Micro Biosystems brought in $33.59M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 19.7% from $28.05M in fiscal 2024. Product was the largest at $23.43M (69.7%), ahead of Service at $10.16M (30.3%).
Compared with fiscal 2024, Product grew 25.1% to $23.43M and Service grew 9.0% to $10.16M. From fiscal 2022 to 2025, combined revenue from these lines grew from $17.13M to $33.59M, a compound annual growth rate of 25.2%. Product's share of the total rose from 64.5% to 69.7%.
Recurring was Rapid Micro Biosystems’s largest revenue line in fiscal 2025, bringing in $17.84M of $33.59M (53%).
| Contract with Customer, Duration | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Recurring | $10.98M | $13.55M | $15.45M | $17.84M | |
| Non-Recurring | $6.15M | $8.97M | $12.60M | $15.75M | |
| Total | $17.13M | $22.52M | $28.05M | $33.59M |
Rapid Micro Biosystems brought in $33.59M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 19.7% from $28.05M in fiscal 2024. Recurring was the largest at $17.84M (53.1%), ahead of Non-Recurring at $15.75M (46.9%).
Compared with fiscal 2024, Non-Recurring grew 25.0% to $15.75M and Recurring grew 15.5% to $17.84M. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $17.13M to $33.59M, a compound annual growth rate of 25.2%. Recurring's share of the total fell from 64.1% to 53.1%.
Rapid Micro Biosystems (RPID) reports its revenue by geography, by product and service and by contract with customer, duration. In fiscal 2025, United States was its largest region, bringing in $13.43M (40.0% of the total), followed by Switzerland at $6.02M (17.9%).
United States was Rapid Micro Biosystems' largest region in fiscal 2025, bringing in $13.43M, or 40.0% of the $33.59M total across its five regions.
Product was Rapid Micro Biosystems' largest product and service line in fiscal 2025, bringing in $23.43M, or 69.7% of the $33.59M total across its two product and service lines.
Recurring was Rapid Micro Biosystems' largest revenue line in fiscal 2025, bringing in $17.84M, or 53.1% of the $33.59M total across its two revenue lines.
Among Rapid Micro Biosystems' regions that make up at least 2% of revenue, Germany grew fastest in fiscal 2025, up 89.2% from $3.05M to $5.77M.
Every figure comes from Rapid Micro Biosystems' annual financial filings, as reported. Each line keeps the name Rapid Micro Biosystems gives it, and years follow its fiscal calendar.
Rapid Micro Biosystems' revenue by geography goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.